Enrolling Studies
Below are our enrolling studies. This page is updated frequently. Please check back often and follow us on social media for the latest updates.
Vaginal Pain Study
This study is to evaluate the safety and effectiveness of the study drug in preventing vaginal pain in postmenopausal women during sexual activity.
For this study, we are looking for women who:
- Postmenopausal
- Between 40 and 75 years of age
- Experience vaginal pain during sexual activity
Please contact us if you are interested in participating in this study or would like more information.
Serene Birth Control Study
This clinical study is to evaluate the safety and effectiveness of the study drug in preventing pregnancy in women with symptomatic endometriosis or uterine fibroids. This study drug has been approved by the FDA to manage heavy menstrual bleeding associated with uterine fibroids and moderate-to-severe pain associated with endometriosis.
For this study, we are looking for women who:
- Are 18 to 50 years of age and have regular monthly menstrual periods that are between 21 and 35 days (about a week of bleeding with 3-4 weeks of no bleeding between periods)
- Have a diagnosis of either uterine fibroids with heavy menstrual bleeding or endometriosis with moderate-to-severe pain
- Be sexually active and at risk of pregnancy. To be considered “sexually active” in this study you must be having vaginal intercourse at least once per month with a male partner (who has not had a vasectomy and is not known to be infertile). To be considered “at risk of pregnancy” you cannot have had your tubes tied/removed/blocked and cannot have a history of difficulty becoming pregnant or infertility
- Be willing to use the study drug as your only method of birth control for one year (for example: pills, rings, shots, patches, condoms, diaphragms, and withdrawal/”the pullout method” are not allowed)
- Agree to complete a daily electronic diary (eDiary)
Please contact us if you are interested in participating in this study or would like more information.
elaris EM-COC Endometriosis Study
The elaris EM-COC Study is evaluating whether the study medication, when taken together with an approved birth control pill, may reduce moderate-to-severe endometriosis pain.
This study will include at least 14 office visits over a period of 21-45 months.
We are looking for women who:
- Are premenopausal between the ages of 18 and 49
- Have had a surgical diagnosis of endometriosis
- Have moderate-to-severe pain from endometriosis
- Do not use tobacco or have a history of smoking (33 years or older)
- Are not pregnant, actively trying to get pregnant or breastfeeding
- Do not have osteoporosis (thinning, weak bones) or any other bone disease
Please contact us if you are interested in participating in this study or would like more information.
Calliop3 Study
Calliop3 is exploring whether a study medication called LPRI-CF113 is an effective birth control for women ages 18-45.
The study medication is designed to prevent pregnancy by blocking the release of a woman’s egg. This may help reduce or stop monthly bleeds. The study medication may also avoid side effects such as weight gain and bloating.
This study includes two office visits, routine phone calls from study staff and daily electronic diary entries over the course of approximately 1 year.
For this study we looking for women who:
- Are sexually active
- Have been regularly menstruating for at least 3 months
Please contact us if you are interested in participating in this study or would like more information.
IT001-310 (UTI) Study
This study is comparing the effectiveness of a new antibiotic UTI medication to amoxicillin/ciavulanate in women with an uncomplicated urinary tract infection (uUTI).
Study participation lasts about 1 month and will include 4 clinic visits and a daily diary.
We are looking for women who:
- Are 18+
- Experiencing uUTI symptoms including frequent/urgent urination, painful or burning urination, and/or pain in the lower abdomen
- Have had symptoms between 1-4 days
- Have NOT taken antibiotics for a uUTI within the past 7 days
Please contact us if you are interested in participating in this study or would like more information.
